Cellyan Biotechnology Co., Ltd (HKPD) stock
HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
$1.33−0.19 (-12.76%)
Close on Nov 18, 2026Market cap $21.75MP/E –Yield –
Cellyan Biotechnology operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2026 it was -$2.39M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$2.39M | – |
| FY2025 | Mar 31, 2025 | -$2.28M | – |
| FY2024 | Mar 31, 2024 | -$1.95M | – |
| FY2023 | Mar 31, 2023 | -$1.79M | – |
See a number that looks wrong?